The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – today said studies at this year’s ASH hematology-oncology conference may change treatment protocols for myeloma patients. The findings are to be presented at the 55th annual meeting of the American Society of Hematology in New Orleans, December 7th through 10th. More than 20,000 blood disease specialists from around the world are expected to attend.
Help employers find you! Check out all the jobs and post your resume.
